Literature DB >> 10626833

Enhanced transgene expression in rat brain cell cultures with a disulfide-containing cationic lipid.

P S Ajmani1, F Tang, S Krishnaswami, E M Meyer, C Sumners, J A Hughes.   

Abstract

The transfection efficiency of a disulfide-containing cationic lipid, 1',2' dioleoyl-sn-glycero-3'-succinyl-2-hydroxyethyl disulfide ornithine conjugate (DOGSDSO) and its non-disulfide analog (DOGSHDO) were compared in neuronal, astroglial and microglial cultures from newborn rat cerebral cortex. We hypothesized that the relatively high intracellular concentrations of reductive substances in the cytoplasm may help to cleave the reversible disulfide bond in DOGSDSO, thus increasing free DNA and decreasing toxicity due to rapid degradation of the lipid. We have demonstrated through mass spectrometric analysis that a reductive compound, e.g. dithiothreitol (DTT) could degrade the disulfide lipid. DOGSDSO was more efficient at transfecting each type of brain cell than were the non-disulfide DOGSHDO and DOTAP (1,2-dioleoyl-3-trimethyl-ammonium-propane) liposomes. These results demonstrate that disulfide-containing cationic liposomes facilitate gene transfection in cultured rat brain cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10626833     DOI: 10.1016/s0304-3940(99)00856-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Transgene delivery with a cationic lipid in the presence of amyloid beta (betaAP) peptide.

Authors:  P S Ajmani; W Wang; F Tang; M A King; E M Meyer; J A Hughes
Journal:  Neurochem Res       Date:  2001-03       Impact factor: 3.996

2.  Incorporation of DOPE into Lipoplexes formed from a Ferrocenyl Lipid leads to Inverse Hexagonal Nanostructures that allow Redox-Based Control of Transfection in High Serum.

Authors:  John P E Muller; Burcu S Aytar; Yukishige Kondo; David M Lynn; Nicholas L Abbott
Journal:  Soft Matter       Date:  2012-05-17       Impact factor: 3.679

Review 3.  Non-viral gene therapy for spinal cord regeneration.

Authors:  Li Yao; Sheng Yao; William Daly; William Hendry; Anthony Windebank; Abhay Pandit
Journal:  Drug Discov Today       Date:  2012-05-24       Impact factor: 7.851

Review 4.  Gene-Modified Stem Cells for Spinal Cord Injury: a Promising Better Alternative Therapy.

Authors:  Yirui Feng; Yu Li; Ping-Ping Shen; Bin Wang
Journal:  Stem Cell Rev Rep       Date:  2022-05-19       Impact factor: 5.739

5.  Chemical activation of lipoplexes formed from DNA and a redox-active, ferrocene-containing cationic lipid.

Authors:  Christopher M Jewell; Melissa E Hays; Yukishige Kondo; Nicholas L Abbott; David M Lynn
Journal:  Bioconjug Chem       Date:  2008-11-19       Impact factor: 4.774

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.